EP3953338A4 - Conjugates and their use as imaging agents - Google Patents

Conjugates and their use as imaging agents Download PDF

Info

Publication number
EP3953338A4
EP3953338A4 EP20788472.7A EP20788472A EP3953338A4 EP 3953338 A4 EP3953338 A4 EP 3953338A4 EP 20788472 A EP20788472 A EP 20788472A EP 3953338 A4 EP3953338 A4 EP 3953338A4
Authority
EP
European Patent Office
Prior art keywords
conjugates
imaging agents
imaging
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20788472.7A
Other languages
German (de)
French (fr)
Other versions
EP3953338A1 (en
Inventor
Philip Hogg
Ivan HO SHON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centenary Institute of Cancer Medicine and Cell Biology
University of Sydney
Original Assignee
Centenary Institute of Cancer Medicine and Cell Biology
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019901277A external-priority patent/AU2019901277A0/en
Application filed by Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney filed Critical Centenary Institute of Cancer Medicine and Cell Biology
Publication of EP3953338A1 publication Critical patent/EP3953338A1/en
Publication of EP3953338A4 publication Critical patent/EP3953338A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66Arsenic compounds
    • C07F9/70Organo-arsenic compounds
    • C07F9/74Aromatic compounds
    • C07F9/78Aromatic compounds containing amino groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP20788472.7A 2019-04-12 2020-04-09 Conjugates and their use as imaging agents Pending EP3953338A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2019901277A AU2019901277A0 (en) 2019-04-12 Conjugates and their use as imaging agents
PCT/AU2020/050359 WO2020206503A1 (en) 2019-04-12 2020-04-09 Conjugates and their use as imaging agents

Publications (2)

Publication Number Publication Date
EP3953338A1 EP3953338A1 (en) 2022-02-16
EP3953338A4 true EP3953338A4 (en) 2023-06-07

Family

ID=72750792

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20788472.7A Pending EP3953338A4 (en) 2019-04-12 2020-04-09 Conjugates and their use as imaging agents

Country Status (7)

Country Link
US (2) US20220152229A1 (en)
EP (1) EP3953338A4 (en)
JP (1) JP2022529335A (en)
CN (1) CN114206844A (en)
AU (1) AU2020256682A1 (en)
CA (1) CA3136647A1 (en)
WO (1) WO2020206503A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL302033A (en) * 2020-10-14 2023-06-01 Centenary Inst Of Cancer Medicine And Cell Biology Therapeutic radiolabelled conjugates and their use in therapy
WO2023060317A1 (en) * 2021-10-14 2023-04-20 Centenary Institute Of Cancer Medicine And Cell Biology Processes for preparing radiolabelled conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HO SHON I A ET AL: "Comparison of a novel Hsp90 ligand radiolabelled with Indium-111 and Gallium-67 for imaging of cell death and dosimetry estimations", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 39, no. Suppl 2, 1 January 2012 (2012-01-01), pages S215 - S216, XP055870365 *
R. A. DUMONT ET AL: "Novel 64Cu- and 68Ga-labeled RGD conjugates show improved PET imaging of alpha V beta 3 Integrin expression and facile radiosynthesis", THE JOURNAL OF NUCLEAR MEDICINE, vol. 52, no. 8, 15 July 2011 (2011-07-15), US, pages 1276 - 1284, XP055747640, ISSN: 0161-5505, DOI: 10.2967/jnumed.111.087700 *
SARKO D. ET AL: "Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological Diseases", CURRENT MEDICINAL CHEMISTRY, vol. 19, no. 17, 1 May 2012 (2012-05-01), NL, pages 2667 - 2688, XP093040867, ISSN: 0929-8673, DOI: 10.2174/092986712800609751 *
See also references of WO2020206503A1 *

Also Published As

Publication number Publication date
JP2022529335A (en) 2022-06-21
WO2020206503A9 (en) 2021-05-06
US20220152229A1 (en) 2022-05-19
US20240009330A1 (en) 2024-01-11
EP3953338A1 (en) 2022-02-16
AU2020256682A1 (en) 2021-11-04
CN114206844A (en) 2022-03-18
CA3136647A1 (en) 2020-10-15
WO2020206503A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
EP3732185A4 (en) Conjugates and preparation and use thereof
IL286291A (en) Compounds and conjugates thereof
EP3797796A4 (en) Antibody-drug conjugate and application thereof
EP3946320A4 (en) Hsp90-binding conjugates and formulations thereof
IL290141A (en) Anti-pvrig antibodies formulations and uses thereof
EP4043034A4 (en) Lysosome-targeting antibody-drug conjugate and application thereof
EP3843736A4 (en) Isoquinoline-steroid conjugates and uses thereof
EP3723811A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3836971A4 (en) Conjugates and methods of using the same
EP3773670A4 (en) Hsp90-targeting conjugates and formulations thereof
EP4031520A4 (en) Imaging and therapeutic compositions
EP4063489A4 (en) Composition and use thereof
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3890721A4 (en) Monomethyl fumarate-carrier conjugates and methods of their use
EP3953338A4 (en) Conjugates and their use as imaging agents
EP4037709A4 (en) Knottin-immunostimulant conjugates and related compositions and methods
EP3915978A4 (en) N-benzyl-n-arylsulfonamide derivative and preparation and use thereof
EP3853213A4 (en) Shielding agents and their use
IL290424A (en) Conjugate and uses thereof
EP3993874A4 (en) Cd38-binding agents and uses thereof
EP3993818A4 (en) Cd38-binding agents and uses thereof
AU2019901277A0 (en) Conjugates and their use as imaging agents
EP3897618A4 (en) Parasiticidal formulations and use thereof
EP3700533A4 (en) Sstr-targeted conjugates and formulations thereof
EP3684425A4 (en) Tetrapyrrolic conjugates and uses thereof for imaging

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211112

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HO SHON, IVAN

Inventor name: HOGG, PHILIP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230508

RIC1 Information provided on ipc code assigned before grant

Ipc: C07B 59/00 20060101ALI20230428BHEP

Ipc: A61K 103/00 20060101ALI20230428BHEP

Ipc: A61K 51/08 20060101ALI20230428BHEP

Ipc: A61K 51/04 20060101ALI20230428BHEP

Ipc: C07F 9/66 20060101ALI20230428BHEP

Ipc: A61K 49/10 20060101ALI20230428BHEP

Ipc: A61K 49/04 20060101ALI20230428BHEP

Ipc: C07D 255/02 20060101AFI20230428BHEP